Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinomas”

27,290 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27,290 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05608876
What this trial is testing

A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
QBiotics Group Limited 15
Not applicableStudy completedNCT00751140
What this trial is testing

Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection

Who this might be right for
Cancer of the Urinary Tract
H. Lee Moffitt Cancer Center and Research Institute 20
Not applicableUnknownNCT00730860
What this trial is testing

Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE

Who this might be right for
Cancer of Liver
Southwest Hospital, China 140
Post-approval studies (Phase 4)Active Not RecruitingNCT04032860
What this trial is testing

RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection

Who this might be right for
HCCHBV Coinfection
West China Hospital 104
Testing effectiveness (Phase 2)Ended earlyNCT04880382
What this trial is testing

Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients

Who this might be right for
Non Small Cell Lung Cancer
Institut Bergonié 8
Early research (Phase 1)Study completedNCT02544880
What this trial is testing

PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Cancer
Donald T. Weed, MD, FACS 16
Testing effectiveness (Phase 2)Study completedNCT04107103
What this trial is testing

Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma

Who this might be right for
SCCHN
AHS Cancer Control Alberta 6
Large-scale testing (Phase 3)Looking for participantsNCT06235203
What this trial is testing

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University 154
Large-scale testing (Phase 3)Looking for participantsNCT06927986
What this trial is testing

Phase III Trial of SYS6010 Versus Platinum-based Chemotherapy for EGFR-mutated NSCLC（SYNSTAR01）

Who this might be right for
EGFR-mutated Locally Advanced or Metastatic NSCLC
CSPC Megalith Biopharmaceutical Co.,Ltd. 380
Large-scale testing (Phase 3)Active Not RecruitingNCT05336786
What this trial is testing

Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)

Who this might be right for
Prostate Carcinoma
Thomas Jefferson University 70
Not applicableUnknownNCT02238769
What this trial is testing

18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 80
Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Not applicableEnded earlyNCT02494635
What this trial is testing

Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer

Who this might be right for
Bladder Papillary Urothelial CarcinomaStage 0a Bladder Urothelial CarcinomaStage 0is Bladder Urothelial Carcinoma+5 more
University of Southern California 4
Not applicableStudy completedNCT06960135
What this trial is testing

Trifecta Achievement in Open and Laparoscopic Partial Nephrectomy

Who this might be right for
Trifecta AchievementPentafecta Achievement
South Valley University 70
Testing effectiveness (Phase 2)WithdrawnNCT03623776
What this trial is testing

Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.

Who this might be right for
Efficacy and Safety
Sun Yat-sen University
Testing effectiveness (Phase 2)WithdrawnNCT04611776
What this trial is testing

A Study Evaluating the Efficacy and Safety of Adjuvant Platinum-Doublet Chemotherapy, With or Without Atezolizumab, in Patients Who Are ctDNA Positive After Complete Surgical Resection of Stage IB to Select IIIB Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Hoffmann-La Roche
Testing effectiveness (Phase 2)Looking for participantsNCT06470217
What this trial is testing

Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 116
Early research (Phase 1)UnknownNCT03282617
What this trial is testing

Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer
National University Hospital, Singapore 55
Testing effectiveness (Phase 2)Ended earlyNCT02748889
What this trial is testing

Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer ( SCLC )
Giuseppe Giaccone 1
Early research (Phase 1)WithdrawnNCT02105350
What this trial is testing

MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer

Who this might be right for
Biliary Tract CarcinomaGallbladder Carcinoma
University Health Network, Toronto
Load More Results